• Biocelect

Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

Updated: Jul 16, 2020

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of

ARAKODA (tafenoquine) for COVID-19

Find full press release in attachment below

Tafenoquine Press Release July 2020
Download PDF • 202KB

Please find the link and attached document of the published article and findings below

Dow et al 2020 TQ COVID 19 20200708
Download PDF • 324KB

Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon